If left untreated, kidney disease can eventually lead to death — which is why early testing is so important. However, the main test has historically had different threshold requirements based on race, which has led to lower diagnosing rates and higher death rates from the condition in people of color. Experts dissect how a new testing equation will help even the scales and give accurate results for all patients.
Guest Information:
- La’Tonzia Adams, MD, MS, FCAP, member of the College of American Pathologists Professional and Community Engagement Committee
- Jonathan Genzen, MD, PhD, FCAP, Chair, College of American Pathologists Clinical Chemistry Committee
Leave a Reply